2023-11-012024-10-312024-10-31false11001529DOCTOR DANCE LTD2025-06-16falseiso4217:GBPxbrli:pure110015292023-11-01110015292024-10-31110015292023-11-012024-10-31110015292022-11-01110015292023-10-31110015292022-11-012023-10-3111001529bus:SmallEntities2023-11-012024-10-3111001529bus:AuditExempt-NoAccountantsReport2023-11-012024-10-3111001529bus:FullAccounts2023-11-012024-10-3111001529bus:PrivateLimitedCompanyLtd2023-11-012024-10-3111001529core:WithinOneYear2024-10-3111001529core:AfterOneYear2024-10-3111001529core:WithinOneYear2023-10-3111001529core:AfterOneYear2023-10-311100152912023-11-012024-10-3111001529core:ShareCapital2024-10-3111001529core:SharePremium2024-10-3111001529core:RevaluationReserve2024-10-3111001529core:OtherReservesSubtotal2024-10-3111001529core:RetainedEarningsAccumulatedLosses2024-10-3111001529core:ShareCapital2023-10-3111001529core:SharePremium2023-10-3111001529core:RevaluationReserve2023-10-3111001529core:OtherReservesSubtotal2023-10-3111001529core:RetainedEarningsAccumulatedLosses2023-10-3111001529core:LandBuildings2024-10-3111001529core:PlantMachinery2024-10-3111001529core:Vehicles2024-10-3111001529core:FurnitureFittings2024-10-3111001529core:OfficeEquipment2024-10-3111001529core:NetGoodwill2024-10-3111001529core:IntangibleAssetsOtherThanGoodwill2024-10-3111001529core:ListedExchangeTraded2024-10-3111001529core:UnlistedNon-exchangeTraded2024-10-3111001529core:LandBuildings2023-10-3111001529core:PlantMachinery2023-10-3111001529core:Vehicles2023-10-3111001529core:FurnitureFittings2023-10-3111001529core:OfficeEquipment2023-10-3111001529core:NetGoodwill2023-10-3111001529core:IntangibleAssetsOtherThanGoodwill2023-10-3111001529core:ListedExchangeTraded2023-10-3111001529core:UnlistedNon-exchangeTraded2023-10-3111001529core:LandBuildings2023-11-012024-10-3111001529core:PlantMachinery2023-11-012024-10-3111001529core:Vehicles2023-11-012024-10-3111001529core:FurnitureFittings2023-11-012024-10-3111001529core:OfficeEquipment2023-11-012024-10-3111001529core:NetGoodwill2023-11-012024-10-3111001529core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3111001529core:ListedExchangeTraded2023-11-012024-10-3111001529core:UnlistedNon-exchangeTraded2023-11-012024-10-3111001529core:MoreThanFiveYears2023-11-012024-10-3111001529core:Non-currentFinancialInstruments2024-10-3111001529core:Non-currentFinancialInstruments2023-10-3111001529dpl:CostSales2023-11-012024-10-3111001529dpl:DistributionCosts2023-11-012024-10-3111001529core:LandBuildings2023-11-012024-10-3111001529core:PlantMachinery2023-11-012024-10-3111001529core:Vehicles2023-11-012024-10-3111001529core:FurnitureFittings2023-11-012024-10-3111001529core:OfficeEquipment2023-11-012024-10-3111001529dpl:AdministrativeExpenses2023-11-012024-10-3111001529core:NetGoodwill2023-11-012024-10-3111001529core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3111001529dpl:GroupUndertakings2023-11-012024-10-3111001529dpl:ParticipatingInterests2023-11-012024-10-3111001529dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-3111001529core:ListedExchangeTraded2023-11-012024-10-3111001529dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-3111001529core:UnlistedNon-exchangeTraded2023-11-012024-10-3111001529dpl:CostSales2022-11-012023-10-3111001529dpl:DistributionCosts2022-11-012023-10-3111001529core:LandBuildings2022-11-012023-10-3111001529core:PlantMachinery2022-11-012023-10-3111001529core:Vehicles2022-11-012023-10-3111001529core:FurnitureFittings2022-11-012023-10-3111001529core:OfficeEquipment2022-11-012023-10-3111001529dpl:AdministrativeExpenses2022-11-012023-10-3111001529core:NetGoodwill2022-11-012023-10-3111001529core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3111001529dpl:GroupUndertakings2022-11-012023-10-3111001529dpl:ParticipatingInterests2022-11-012023-10-3111001529dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-012023-10-3111001529core:ListedExchangeTraded2022-11-012023-10-3111001529dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-012023-10-3111001529core:UnlistedNon-exchangeTraded2022-11-012023-10-3111001529core:NetGoodwill2024-10-3111001529core:IntangibleAssetsOtherThanGoodwill2024-10-3111001529core:LandBuildings2024-10-3111001529core:PlantMachinery2024-10-3111001529core:Vehicles2024-10-3111001529core:FurnitureFittings2024-10-3111001529core:OfficeEquipment2024-10-3111001529core:AfterOneYear2024-10-3111001529core:WithinOneYear2024-10-3111001529core:ListedExchangeTraded2024-10-3111001529core:UnlistedNon-exchangeTraded2024-10-3111001529core:ShareCapital2024-10-3111001529core:SharePremium2024-10-3111001529core:RevaluationReserve2024-10-3111001529core:OtherReservesSubtotal2024-10-3111001529core:RetainedEarningsAccumulatedLosses2024-10-3111001529core:NetGoodwill2023-10-3111001529core:IntangibleAssetsOtherThanGoodwill2023-10-3111001529core:LandBuildings2023-10-3111001529core:PlantMachinery2023-10-3111001529core:Vehicles2023-10-3111001529core:FurnitureFittings2023-10-3111001529core:OfficeEquipment2023-10-3111001529core:AfterOneYear2023-10-3111001529core:WithinOneYear2023-10-3111001529core:ListedExchangeTraded2023-10-3111001529core:UnlistedNon-exchangeTraded2023-10-3111001529core:ShareCapital2023-10-3111001529core:SharePremium2023-10-3111001529core:RevaluationReserve2023-10-3111001529core:OtherReservesSubtotal2023-10-3111001529core:RetainedEarningsAccumulatedLosses2023-10-3111001529core:NetGoodwill2022-11-0111001529core:IntangibleAssetsOtherThanGoodwill2022-11-0111001529core:LandBuildings2022-11-0111001529core:PlantMachinery2022-11-0111001529core:Vehicles2022-11-0111001529core:FurnitureFittings2022-11-0111001529core:OfficeEquipment2022-11-0111001529core:AfterOneYear2022-11-0111001529core:WithinOneYear2022-11-0111001529core:ListedExchangeTraded2022-11-0111001529core:UnlistedNon-exchangeTraded2022-11-0111001529core:ShareCapital2022-11-0111001529core:SharePremium2022-11-0111001529core:RevaluationReserve2022-11-0111001529core:OtherReservesSubtotal2022-11-0111001529core:RetainedEarningsAccumulatedLosses2022-11-0111001529core:AfterOneYear2023-11-012024-10-3111001529core:WithinOneYear2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:CostValuation2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-012024-10-3111001529core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3111001529core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3111001529core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3111001529core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3111001529core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3111001529core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3111001529core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3111001529core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3111001529core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3111001529core:Non-currentFinancialInstrumentscore:CostValuation2023-10-3111001529core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-3111001529core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-3111001529core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-3111001529core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-3111001529core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-3111001529core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-3111001529core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-3111001529core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-3111001529bus:Director12023-11-012024-10-3111001529bus:Director22023-11-012024-10-3111001529core:FurnitureFittingsToolsEquipment2023-10-3111001529core:FurnitureFittingsToolsEquipment2023-11-012024-10-3111001529core:FurnitureFittingsToolsEquipment2024-10-31110015291bus:Director22023-11-01110015291bus:Director22023-11-012024-10-31110015291bus:Director22024-10-31110015292023-11-01110015292023-11-012024-10-31110015292024-10-31

DOCTOR DANCE LTD

(formerly DR DANCE PRESENTS LTD)

Registered Number
11001529
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2024

DOCTOR DANCE LTD
Company Information
for the year from 1 November 2023 to 31 October 2024

Directors

LOVATT, Lindsey Marie
LOVATT, Peter John

Registered Address

15 St Mary's Road
Cromer
NR27 9DJ

Registered Number

11001529 (England and Wales)
DOCTOR DANCE LTD
Balance Sheet as at
31 October 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets314,8118,731
14,8118,731
Current assets
Stocks200200
Debtors47,25319,643
Cash at bank and on hand2,3491,770
9,80221,613
Creditors amounts falling due within one year5(16,978)(22,005)
Net current assets (liabilities)(7,176)(392)
Total assets less current liabilities7,6358,339
Creditors amounts falling due after one year6(3,697)(6,059)
Provisions for liabilities(2,721)(1,659)
Net assets1,217621
Capital and reserves
Called up share capital200200
Profit and loss account1,017421
Shareholders' funds1,217621
The financial statements were approved and authorised for issue by the Board of Directors on 16 June 2025, and are signed on its behalf by:
LOVATT, Peter John
Director
Registered Company No. 11001529
DOCTOR DANCE LTD
Notes to the Financial Statements
for the year ended 31 October 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Land and buildings-50
Fixtures and fittings25-
Office Equipment-3
Stocks and work in progress
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
2.Average number of employees

20242023
Average number of employees during the year00
3.Tangible fixed assets

Land & buildings

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 November 237,30675815,63023,694
Additions4,132-4,0938,225
At 31 October 2411,43875819,72331,919
Depreciation and impairment
At 01 November 2357945413,93014,963
Charge for year215761,8542,145
At 31 October 2479453015,78417,108
Net book value
At 31 October 2410,6442283,93914,811
At 31 October 236,7273041,7008,731
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables3,000-
Other debtors-16,317
Prepayments and accrued income4,2533,326
Total7,25319,643
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables6,1254,298
Bank borrowings and overdrafts6,21210,241
Taxation and social security2,4557,466
Other creditors1,891-
Accrued liabilities and deferred income295-
Total16,97822,005
6.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts3,6976,059
Total3,6976,059
7.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
LOVATT, Peter John15,877015,8770
15,877015,8770
The director's loan was repaid on 16 February 2024.
8.Related party transactions
During the year, dividends of £14,500 (2023 - £24,898) were paid to the directors.
9.Controlling party
By way of equal shareholdings, Dr P Lovatt and Mrs L Lovatt share ultimate control of the company between them.